Role of kinins in anaphylactic-induced bronchoconstriction mediated by tachykinins in guinea-pigs
Open Access
- 1 October 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 113 (2) , 508-512
- https://doi.org/10.1111/j.1476-5381.1994.tb17018.x
Abstract
1 In the present study, we have investigated the role of kinins in allergen-induced bronchoconstriction. 2 Anaesthetized guinea-pigs were sensitized to ovalbumin, ventilated artificially, pretreated with atropine (1.4 μmol kg−1, i.v.) and total pulmonary resistance (RL) measured. In preliminary studies in the presence of the neutral endopeptidase inhibitor, phosphoramidon (4.5 μmol kg−1, i.v.), the bradykinin B2 receptor antagonist Hoe 140 (0.1 μmol kg−1, i.v.) completely abolished the increase in RL following aerosolized bradykinin (1 mm, 40 breaths), but had no effect on the increase in RL following aerosolized neurokinin A (NKA, 10μm, 40 breaths). On the other hand, a combination of the NK1 (CP-96,345, 2 μmol kg-1, i.v.) and NK2 (SR 48968, 0.3 μmol kg−1, i.v.) tachykinin receptor antagonists abolished completely the increase in RL produced by NKA and partially inhibited the increase in RL produced by bradykinin. These results confirm previous studies that suggest that bradykinin induces the release of tachykinins from sensory nerves in guinea-pig airways. 3 Aerosolized ovalbumin (0.5%, 5 breaths) increased RL in sensitized guinea-pigs pretreated with atropine (1.4mmol kg−1, i.v.), an effect that began within 2 min and reached a maximum within 5 min; RL remained above baseline at 20 min. Pretreatment with the bradykinin B2 receptor antagonist, Hoe 140, decreased the bronchoconstrictor effect of ovalbumin markedly at 10 to 20 min. In the presence of phosphoramidon (4.5 μmol kg−1, i.v.) the inhibition induced by Hoe 140 was apparent earlier and remained over the 20 min period of study. 4 Pretreatment with a combination of NK1 (CP-96,345) and NK2 (SR 48968) tachykinin receptor antagonists also markedly inhibited ovalbumin-induced bronchoconstriction; addition of the bradykinin B2 receptor antagonist to the NK1 and NK2 tachykinin receptor antagonists had no additional inhibitory effect on antigen-induced bronchoconstriction. 5 These findings confirm that activation of sensory nerves to release tachykinins in guinea-pig airways contribute to antigen-induced bronchoconstriction, and provide evidence that tachykinin release is due to kinins generated during the allergic response.Keywords
This publication has 22 references indexed in Scilit:
- Allergen-induced Biphasic Plasma Exudation Responses in Guinea Pig Large AirwaysAmerican Review of Respiratory Disease, 1993
- Sensory neuropeptide release by bradykinin: mechanisms and pathophysiological implicationsRegulatory Peptides, 1993
- A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptorLife Sciences, 1992
- Effects of bradykinin receptor antagonists on antigen-induced respiratory distress, airway hyperresponsiveness and eosinophilia in guinea-pigsBritish Journal of Pharmacology, 1992
- Hoe 140 a new potent and long acting bradykinin‐antagonist: in vitro studiesBritish Journal of Pharmacology, 1991
- A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) ReceptorScience, 1991
- Simultaneous release by bradykinin of substance P-and calcitonin gene-related peptide immunoreactivities from capsaicin-sensitive structures in guinea-pig heartBritish Journal of Pharmacology, 1988
- ASTHMA AS AN AXON REFLEXThe Lancet, 1986
- Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including manCell and tissue research, 1984
- Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritantsNature, 1983